Ken Getz is the Executive Director of the Tufts Center for the Study of Drug Development and a Research Professor at the Tufts University School of Medicine. He is an internationally recognized expert on pharmaceutical R&D management and execution, protocol design, contract service provider and investigative site management, eClinical technology and data usage, and patient engagement. A well-known speaker at conferences, symposia, universities, investor meetings, and corporations, Ken has published extensively in peer-review journals, books, and in the trade press. He holds a number of board appointments in the private and public sectors. He received his MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and his bachelor’s degree from Brandeis University. Ken is also the chairman of CISCRP — a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise — and the founder of CenterWatch, a leading publisher in the clinical trials industry and one of several businesses that he has sold.
Ken's Current & Recent Research Initiatives Include:
- Quantifying clinical trial participant diversity and disparities
- Benchmarking protocol design practices and their impact on performance
- Examining remote and virtual drug development activity and its effectiveness
- Evaluating the adoption and value proposition/ROI of innovative practices and solutions
- Measuring the impact of regulatory reforms on the cost and efficiency of drug development
- Examining clinical data and real-world data management practices
- Monitoring structural and operating changes in the global investigative site landscape
- Assessing the evolving role of outsourcing and contract services in drug development